Viewing data from:

CARBILEV

ANDA

CARBIDOPA; LEVODOPA | A076643 | RANBAXY LABORATORIES LTD

3 strengths0 unique patents0 unique exclusivities

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jun 14, 2005	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (3)

Sort:

#001 — 10MG;100MG

0 patents0 exclusivities▴

TABLET, FOR SUSPENSION;ORAL | Approved: Jun 10, 2005

No patent or exclusivity listings for this strength.

#002 — 25MG;100MG

0 patents0 exclusivities▾

TABLET, FOR SUSPENSION;ORAL | Approved: Jun 10, 2005

#003 — 25MG;250MG

0 patents0 exclusivities▾

TABLET, FOR SUSPENSION;ORAL | Approved: Jun 10, 2005